Oseltamivir
Treatment of acute, uncomplicated influenza A and B, Prophylaxis of influenza A and B
Indications
- Treatment of acute, uncomplicated influenza A and B
- Prophylaxis of influenza A and B
Adult dosing
- treatment: dose: 75; unit: mg; route: PO; interval: twice daily for 5 days; fixed: true; labelExcerpt: The recommended oral dosage of oseltamivir phosphate for oral suspension for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily (12.5 mL of oral suspension twice daily) for 5 days.
- prophylaxis: dose: 75; unit: mg; route: PO; interval: once daily for at least 10 days; fixed: true; labelExcerpt: The recommended dosage of oseltamivir phosphate for oral suspension for prophylaxis of influenza in adults and adolescents 13 years and older is 75 mg orally once daily (12.5 mL of oral suspension once daily) for at least 10 days following close contact with an infected individual
Pediatric dosing
- treatment infants: dose: 3; unit: mg/kg; route: PO; interval: twice daily for 5 days; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: Pediatric patients 2 weeks to less than 1 year of age: 3mg/kg twice daily for 5 days ( 2.2 )
- treatment 15kg or less: dose: 30; unit: mg; route: PO; interval: twice daily for 5 days (weight based); fixed: true; labelExcerpt: 15 kg or less 30 mg twice daily 30 mg once daily 5 mL 1 bottle
- prophylaxis 15kg or less: dose: 30; unit: mg; route: PO; interval: once daily for 10 days (weight based); fixed: true; labelExcerpt: 15 kg or less 30 mg twice daily 30 mg once daily 5 mL 1 bottle
Renal adjustment
- moderate: 30 mg twice daily for treatment; 30 mg once daily for prophylaxis; severe: 30 mg once daily for treatment; 30 mg every other day for prophylaxis; failure: 30 mg immediately and then 30 mg after hemodialysis for treatment; hemodialysis: 30 mg immediately and then 30 mg after every hemodialysis cycle; note: Adjust dose if CrCl <= 60 mL/min; not recommended for ESRD not on dialysis. Label: "Renally impaired adult patients (creatinine clearance >30 to 60 mL/min): Reduce to 30 mg twice daily for 5 days ( 2.4 ) Renally impaired adult patients (creatinine clearance >10 to 30 mL/min): Reduce to 30 mg once daily for 5 days ( 2.4 ) ESRD patients on hemo"
Hepatic adjustment
- Oseltamivir is converted by hepatic esterases; no specific adjustment stated.
Contraindications
- Known serious hypersensitivity to oseltamivir
Clinical pearls
- Initiate treatment within 48 hours of symptom onset.
- Monitor for neuropsychiatric events (confusion/abnormal behavior), particularly in pediatric patients.
- Oral suspension can be taken with food to improve tolerability.
- Not a substitute for annual influenza vaccination.
Source and review
- DailyMed label (oseltamivir phosphate), Set ID 07958a9a-2360-4380-b7da-5371ed80a271, effective 2026-08-07. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties